-
NUMBER OF INSIDER BUYING
(Last 12 Months)
1 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
10 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$198,736 -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$2.30 M
PTC Therapeutics, Inc. Insider Transactions
PTC Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Gravier Pierre
CHIEF FINANCIAL OFFICER |
Sell | 2,269 @ $34.02 | $77,200 | 53,531 | 07/16/2024 | 07/18/2024 | |
|
ZELDIS JEROME B
Director |
Sell | 20,000 @ $38.24 | $764,800 | 14,500 | 05/22/2024 | 05/24/2024 | |
|
Golden Lee Scott
EVP & CHIEF MEDICAL OFFICER |
Sell | 175 @ $32.82 | $5,744 | 59,813 | 05/07/2024 | 05/08/2024 | |
|
Klein Matthew B.
Director, CHIEF EXECUTIVE OFFICER |
Sell | 3,361 @ $24.89 | $83,669 | 225,807 | 04/19/2024 | 04/22/2024 | |
|
Pauwels Eric
Director, CHIEF EXECUTIVE OFFICER |
Sell | 787 @ $25.14 | $19,781 | 67,694 | 04/17/2024 | 04/19/2024 | |
|
Klein Matthew B.
Director, CHIEF EXECUTIVE OFFICER |
Sell | 1,307 @ $25.14 | $32,851 | 229,168 | 04/17/2024 | 04/19/2024 | |
|
Golden Lee Scott
EVP & CHIEF MEDICAL OFFICER |
Sell | 526 @ $28.37 | $14,923 | 59,988 | 04/02/2024 | 04/04/2024 | |
|
Almstead Neil Gregory
CHIEF TECHNICAL OPS OFFICER |
Sell | 618 @ $27.25 | $16,841 | 61,202 | 01/30/2024 | 02/01/2024 | |
|
Almstead Neil Gregory
CHIEF TECHNICAL OPS OFFICER |
Sell | 28 @ $27.25 | $763 | 3,706 | 01/30/2024 | 02/01/2024 | |
|
Boulding Mark Elliott
EXEC. VP AND CLO |
Sell | 794 @ $27.25 | $21,637 | 71,189 | 01/30/2024 | 02/01/2024 | |
|
Pauwels Eric
CHIEF BUSINESS OFFICER |
Sell | 366 @ $27.25 | $9,974 | 44,181 | 01/30/2024 | 02/01/2024 | |
|
Utter Christine Marie
SVP, CHIEF ACCOUNTING OFFICER |
Sell | 318 @ $27.25 | $8,666 | 35,528 | 01/30/2024 | 02/01/2024 | |
|
Jacobson Allan Steven
Director |
Sell | 10,000 @ $27.38 | $273,804 | 12,348 | 01/22/2024 | 01/24/2024 | |
|
Utter Christine Marie
SVP, FINANCE & CAO |
Sell | 1,653 @ $29.01 | $47,961 | 35,846 | 01/09/2024 | 01/10/2024 | |
|
Pauwels Eric
CHIEF BUSINESS OFFICER |
Sell | 2,065 @ $29.01 | $59,916 | 44,547 | 01/09/2024 | 01/10/2024 | |
|
Klein Matthew B.
Director, CHIEF EXECUTIVE OFFICER |
Sell | 5,443 @ $29.01 | $157,928 | 160,475 | 01/09/2024 | 01/10/2024 | |
|
Golden Lee Scott
CHIEF MEDICAL OFFICER |
Sell | 1,225 @ $29.01 | $35,543 | 37,914 | 01/09/2024 | 01/10/2024 | |
|
Boulding Mark Elliott
EXEC. VP AND CLO |
Sell | 1,938 @ $29.01 | $56,231 | 71,983 | 01/09/2024 | 01/10/2024 | |
|
Almstead Neil Gregory
CHIEF TECHNICAL OPS OFFICER |
Sell | 1,521 @ $29.01 | $44,132 | 61,820 | 01/09/2024 | 01/10/2024 | |
|
Almstead Neil Gregory
CHIEF TECHNICAL OPS OFFICER |
Sell | 100 @ $29.01 | $2,901 | 3,734 | 01/09/2024 | 01/10/2024 |
PTC Therapeutics, Inc. Frequently Asked Questions
-
Who is on PTC Therapeutics, Inc.'s Insider Roster?
The list of insiders at PTC Therapeutics, Inc. includes Gravier Pierre, Klein Matthew B., Almstead Neil Gregory, Boulding Mark Elliott, Golden Lee Scott, Pauwels Eric, SCHMERTZLER MICHAEL, Utter Christine Marie, Jacobson Allan Steven, ZELDIS JEROME B.
-
How much insider selling is happening at PTC Therapeutics, Inc.?
Insiders have sold a total of 74,616 PTC Therapeutics, Inc. shares in the last 12 months for a total of 2.30 M sold.
-
Which PTC Therapeutics, Inc. insiders have been selling company stock?
The following insiders have sold PTC Therapeutics, Inc. shares in the last 12 months: Klein Matthew B. ($612,909), Almstead Neil Gregory ($101,554), Boulding Mark Elliott ($119,597), Golden Lee Scott ($78,405), Pauwels Eric ($134,607), SCHMERTZLER MICHAEL ($41,715), Utter Christine Marie ($90,652), Jacobson Allan Steven ($273,804), ZELDIS JEROME B ($764,800), Gravier Pierre ($77,200),
-
How much insider buying is happening at PTC Therapeutics, Inc.?
Insiders have purchased a total of 7,700 PTC Therapeutics, Inc. shares in the last 12 months for a total of 198,736 sold.
-
Which PTC Therapeutics, Inc. insiders have been buying company stock?
The following insiders have purchased PTC Therapeutics, Inc. shares in the last 12 months: Gravier Pierre ($198,736),